Efficacy Study to Treat Subjects With Severe Hypertriglyceridemia

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2010
The primary objective is to determine the efficacy of AKR963 compared to placebo and active comparator in lowering fasting triglyceride levels in patients with very high fasting triglyceride levels ≥ 500 and ≤ 1500 mg/dL.
Epistemonikos ID: f0d6e75d5b825b15ad8649baa6ff2d3ab1bd227f
First added on: May 06, 2024